Richard C. Franson

3.0k total citations
67 papers, 2.5k citations indexed

About

Richard C. Franson is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Richard C. Franson has authored 67 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 15 papers in Physiology. Recurrent topics in Richard C. Franson's work include Protein Kinase Regulation and GTPase Signaling (20 papers), Venomous Animal Envenomation and Studies (12 papers) and Biomedical Research and Pathophysiology (10 papers). Richard C. Franson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (20 papers), Venomous Animal Envenomation and Studies (12 papers) and Biomedical Research and Pathophysiology (10 papers). Richard C. Franson collaborates with scholars based in United States, Switzerland and Germany. Richard C. Franson's co-authors include Jeffrey A. Saal, Joel S. Saal, Bannikuppe S. Vishwanath, Miriam D. Rosenthal, Robert L. Jesse, Noel Goldthwaite, Robert J. Dobrow, Arthur H. White, Jerrold Weiss and Peter Elsbach and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Richard C. Franson

65 papers receiving 2.4k citations

Peers

Richard C. Franson
Peter Thomas United States
Fajun Yang United States
Sergio A. Lamprecht Israel
Charles S. Hii Australia
Shunhei Yamashina Japan
Daniel V. Kimberg United States
Vincent A. Ziboh United States
Kyu‐Shik Jeong South Korea
Gary F. Merrill United States
Tongtong Zou United States
Peter Thomas United States
Richard C. Franson
Citations per year, relative to Richard C. Franson Richard C. Franson (= 1×) peers Peter Thomas

Countries citing papers authored by Richard C. Franson

Since Specialization
Citations

This map shows the geographic impact of Richard C. Franson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Franson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Franson more than expected).

Fields of papers citing papers by Richard C. Franson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Franson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Franson. The network helps show where Richard C. Franson may publish in the future.

Co-authorship network of co-authors of Richard C. Franson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Franson. A scholar is included among the top collaborators of Richard C. Franson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Franson. Richard C. Franson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ockaili, Ramzi, Fadi N. Salloum, Christopher K. Mehta, Richard C. Franson, & Rakesh C. Kukreja. (2007). Abstract 1554: PX-18 - A Novel Inhibitor of Type IIA Secretory Phospholipase A2 Induces Pre and Post-Conditioning against Myocardial Infarction in Rabbit: Role of Mitochondrial KATP Channels.. Circulation. 116. 1 indexed citations
2.
Sonnino, Roberta, et al.. (1998). Early secretory events during intestinal graft preservation. Transplantation Proceedings. 30(6). 2643–2643.
3.
Franson, Richard C. & Miriam D. Rosenthal. (1997). PX-52, a Novel Inhibitor of 14 kDa Secretory and 85 kDa Cytosolic Phospholipases A2. Advances in experimental medicine and biology. 400A. 365–373. 5 indexed citations
4.
Rosenthal, Miriam D., et al.. (1995). Human Neutrophils Store Type II 14-kDa Phospholipase A2 in Granules and Secrete Active Enzyme in Response to Soluble Stimuli. Biochemical and Biophysical Research Communications. 208(2). 650–656. 78 indexed citations
5.
Tramposch, Kenneth M., Paul Stanley, David O. Nettleton, et al.. (1992). Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity. Biochemical and Biophysical Research Communications. 189(1). 272–279. 27 indexed citations
6.
Franson, Richard C., et al.. (1992). Sphingolipid metabolism and signal transduction: inhibition of in vitro phospholipase activity by sphingosine. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1136(2). 169–174. 31 indexed citations
7.
Franson, Richard C., Joel S. Saal, & Jeffrey A. Saal. (1992). Human Disc Phospholipase A2 is Inflammatory. Spine. 17(Supplement). S129–S132. 155 indexed citations
8.
9.
Raghupathi, Ramesh & Richard C. Franson. (1992). Inhibition of phospholipase A2 by cis-unsaturated fatty acids: evidence for the binding of fatty acid to enzyme. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1126(2). 206–214. 21 indexed citations
10.
Ghosh, Sanjay & Richard C. Franson. (1992). Use of [1-14C]oleate labelled autoclaved Escherichia coli as a membranous substrate for measurement of in vitro phospholipase D activity. Biochemistry and Cell Biology. 70(1). 43–48. 3 indexed citations
11.
Franson, Richard C., et al.. (1990). Characterization and partial purification of soluble, lysosomal phospholipase(s) A2 from adrenal medulla. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1042(2). 247–254. 10 indexed citations
12.
Saal, Joel S., Richard C. Franson, Robert J. Dobrow, et al.. (1990). High Levels of Inflammatory Phospholipase A2 Activity in Lumbar Disc Herniations. Spine. 15(7). 674–678. 414 indexed citations
13.
Franson, Richard C., et al.. (1990). Biomembrane-modulated, lysosomal phospholipase A2 contamination of chromaffin granule ghosts. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1029(1). 196–200. 4 indexed citations
14.
Franson, Richard C. & Miriam D. Rosenthal. (1989). Oligomers of prostaglandin B1 inhibit in vitro phospholipase A2 activity. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1006(3). 272–277. 18 indexed citations
15.
Franson, Richard C., et al.. (1989). Phospholipid metabolism in polymorphonuclear leukocytes from rheumatoid arthritis patients: Effects of non-steroidal anti-inflammatory agents and clotrimazole. International Journal of Immunopharmacology. 11(1). 45–55. 5 indexed citations
16.
Vishwanath, Bannikuppe S., et al.. (1988). Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation. 12(6). 549–561. 139 indexed citations
17.
Vishwanath, Bannikuppe S., et al.. (1988). Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Inflammation Research. 25(3-4). 394–400. 67 indexed citations
18.
Raghupathi, Ramesh & Richard C. Franson. (1987). Isolation of a Ca/sup + +/-dependent phospholipase A/sub 2/ from human platelets. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
19.
Gamache, Daniel A., et al.. (1987). Phospholipid alterations in canine cardiac sarcoplasmic reticulum induced by an acid-active phospholipase C. Steinkopff eBooks. 82 Suppl 1. 113–119. 2 indexed citations
20.
Franson, Richard C., et al.. (1987). Modulation of phospholipase A2 activity in human synovial fluid by cations. Inflammation. 11(4). 389–400. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Thomas Breakdown of academic impact, for papers by Fajun Yang Breakdown of academic impact, for papers by Sergio A. Lamprecht Breakdown of academic impact, for papers by Charles S. Hii Breakdown of academic impact, for papers by Shunhei Yamashina Breakdown of academic impact, for papers by Daniel V. Kimberg Breakdown of academic impact, for papers by Vincent A. Ziboh Breakdown of academic impact, for papers by Kyu‐Shik Jeong Breakdown of academic impact, for papers by Gary F. Merrill Breakdown of academic impact, for papers by Tongtong Zou
Rankless by CCL
2026